Fig. 3From: Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosisExpression of semaphorin 3E (Sema3E) in skin of healthy controls and patients with systemic sclerosis (SSc). a, b Representative microphotographs of skin sections from healthy controls (a) (n = 12) and patients with SSc (b) (n = 14) immunostained for Sema3E (green) and counterstained with 4′,6-diamidino-2-phenylindole (DAPI; blue) for nuclei. c-f Representative microphotographs of skin sections from healthy controls (c, e) (n = 12) and patients with SSc (d, f) (n = 14) double immunostained for Sema3E (green) and CD31/platelet-endothelial cell adhesion molecule-1 (PECAM-1) (red) and counterstained with DAPI (blue). Arrows indicate Sema3E expression in dermal microvascular endothelial cells. Original magnification: × 20 (a, b), × 40 (c, d), × 63 (e, f). Scale bars are indicated in each panel. g Densitometric analysis of Sema3E immunofluorescent staining in skin biopsies expressed as optical density (OD) in arbitrary units (a.u.). Control skin OD value was set to 100 %; the other results are normalized to this value. Data are mean ± SD. Student’s t test was used for statistical analysisBack to article page